Application of population pharmacokinetic modeling to explore the impact of alternative roflumilast dosing regimens on tolerability

Gezim Lahu; Axel Facius

doi:10.5414/cp201906

Application of population pharmacokinetic modeling to explore the impact of alternative roflumilast dosing regimens on tolerability

International Journal of Clinical Pharmacology and Therapeutics ◽

10.5414/cp201906 ◽

2013 ◽

Vol 51 (11) ◽

pp. 832-836 ◽

Cited By ~ 6

Author(s):

Gezim Lahu ◽

Axel Facius

Keyword(s):

Pharmacokinetic Modeling ◽

Population Pharmacokinetic ◽

Population Pharmacokinetic Modeling ◽

Dosing Regimens ◽

The Impact

Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis

The Journal of Clinical Pharmacology ◽

10.1002/jcph.810 ◽

2016 ◽

Vol 57 (3) ◽

pp. 336-344 ◽

Cited By ~ 6

Author(s):

Hongmei Xu ◽

Wangda Zhou ◽

Diansong Zhou ◽

Jianguo Li ◽

Nidal Al-Huniti

Keyword(s):

Monte Carlo Simulation ◽

Monte Carlo ◽

Renal Function ◽

Impaired Renal Function ◽

Simulation Analysis ◽

Pharmacokinetic Modeling ◽

Population Pharmacokinetic ◽

Population Pharmacokinetic Modeling ◽

Dosing Regimens

025 Population Pharmacokinetic Modeling and Simulation to Assess the Impact of an 8 Week Maintenance Dosing Regimen for Intramuscular Testosterone Undecanoate

Journal of Sexual Medicine ◽

10.1016/j.jsxm.2021.01.095 ◽

2021 ◽

Vol 18 (3) ◽

pp. S15

Author(s):

A. Pastuszak ◽

M. Bush ◽

L. Curd ◽

S. Vijayan ◽

T. Priestley ◽

...

Keyword(s):

Modeling And Simulation ◽

Pharmacokinetic Modeling ◽

Population Pharmacokinetic ◽

Dosing Regimen ◽

Testosterone Undecanoate ◽

Population Pharmacokinetic Modeling ◽

The Impact ◽

Pharmacokinetic Modeling And Simulation

The impact of frailty on pharmacokinetics in older people: using gentamicin population pharmacokinetic modeling to investigate changes in renal drug clearance by glomerular filtration

European Journal of Clinical Pharmacology ◽

10.1007/s00228-014-1652-7 ◽

2014 ◽

Vol 70 (5) ◽

pp. 549-555 ◽

Cited By ~ 33

Author(s):

Claire Johnston ◽

Sarah N. Hilmer ◽

Andrew J. McLachlan ◽

Slade T. Matthews ◽

Peter R. Carroll ◽

...

Keyword(s):

Older People ◽

Glomerular Filtration ◽

Drug Clearance ◽

Pharmacokinetic Modeling ◽

Population Pharmacokinetic ◽

Population Pharmacokinetic Modeling ◽

Renal Drug Clearance ◽

The Impact

Population Pharmacokinetic Modeling to Evaluate Standard Magnesium Sulfate Treatments and Alternative Dosing Regimens for Women With Preeclampsia

The Journal of Clinical Pharmacology ◽

10.1002/jcph.1328 ◽

2018 ◽

Vol 59 (3) ◽

pp. 374-385 ◽

Cited By ~ 4

Author(s):

Lihong Du ◽

Larissa Wenning ◽

Elizabeth Migoya ◽

Yan Xu ◽

Brendan Carvalho ◽

...

Keyword(s):

Magnesium Sulfate ◽

Pharmacokinetic Modeling ◽

Population Pharmacokinetic ◽

Population Pharmacokinetic Modeling ◽

Dosing Regimens

MP45-02 POPULATION PHARMACOKINETIC MODELING AND SIMULATION TO ASSESS THE IMPACT OF AN 8-WEEK MAINTENANCE DOSING REGIMEN FOR INTRAMUSCULAR TESTOSTERONE UNDECANOATE

The Journal of Urology ◽

10.1097/ju.0000000000000900.02 ◽

2020 ◽

Vol 203 ◽

pp. e665

Author(s):

Alexander Pastuszak* ◽

Mark Bush ◽

Laura Curd ◽

Saji Vijayan ◽

Tony Priestley ◽

...

Keyword(s):

Modeling And Simulation ◽

Pharmacokinetic Modeling ◽

Population Pharmacokinetic ◽

Dosing Regimen ◽

Testosterone Undecanoate ◽

Population Pharmacokinetic Modeling ◽

The Impact ◽

Pharmacokinetic Modeling And Simulation

Population Pharmacokinetic Modeling of Etoposide Free Concentrations in Solid Tumor

Pharmaceutical Research ◽

10.1007/s11095-016-1906-4 ◽

2016 ◽

Vol 33 (7) ◽

pp. 1657-1670 ◽

Cited By ~ 6

Author(s):

Maiara Cássia Pigatto ◽

Bibiana Verlindo de Araujo ◽

Bruna Gaelzer Silva Torres ◽

Stephan Schmidt ◽

Paolo Magni ◽

...

Keyword(s):

Solid Tumor ◽

Pharmacokinetic Modeling ◽

Population Pharmacokinetic ◽

Population Pharmacokinetic Modeling

Population pharmacokinetic modeling of molibresib and its active metabolites in patients with solid tumors: a semi‐mechanistic autoinduction model

CPT Pharmacometrics & Systems Pharmacology ◽

10.1002/psp4.12639 ◽

2021 ◽

Author(s):

Anu Shilpa Krishnatry ◽

Alexander Voelkner ◽

Arindam Dhar ◽

Marita Prohn ◽

Geraldine Ferron‐Brady

Keyword(s):

Solid Tumors ◽

Pharmacokinetic Modeling ◽

Population Pharmacokinetic ◽

Active Metabolites ◽

Population Pharmacokinetic Modeling

Current Ceftriaxone Dose Recommendations are Adequate for Most Critically Ill Children: Results of a Population Pharmacokinetic Modeling and Simulation Study

Clinical Pharmacokinetics ◽

10.1007/s40262-021-01035-9 ◽

2021 ◽

Author(s):

Stan J. F. Hartman ◽

Parth J. Upadhyay ◽

Nienke N. Hagedoorn ◽

Ron A. A. Mathôt ◽

Henriëtte A. Moll ◽

...

Keyword(s):

Modeling And Simulation ◽

Critically Ill ◽

Simulation Study ◽

Pharmacokinetic Modeling ◽

Critically Ill Children ◽

Population Pharmacokinetic ◽

Population Pharmacokinetic Modeling ◽

Dose Recommendations ◽

Pharmacokinetic Modeling And Simulation

Population Pharmacokinetic Modeling of Fluticasone Furoate, Umeclidinium Bromide, and Vilanterol in Patients with Asthma, Using Data from a Phase IIIA Study (CAPTAIN)

Clinical Pharmacokinetics ◽

10.1007/s40262-021-00988-1 ◽

2021 ◽

Author(s):

Shuying Yang ◽

Laurie A. Lee ◽

Neal Sule ◽

Andrew Fowler ◽

Guy Peachey

Keyword(s):

Pharmacokinetic Modeling ◽

Population Pharmacokinetic ◽

Fluticasone Furoate ◽

Population Pharmacokinetic Modeling ◽

Using Data

Population Pharmacokinetic Modeling of Mogamulizumab in Adults With Cutaneous T‐Cell Lymphoma or Adult T‐Cell Lymphoma

The Journal of Clinical Pharmacology ◽

10.1002/jcph.1564 ◽

2019 ◽

Vol 60 (1) ◽

pp. 58-66

Author(s):

Mayumi Mukai ◽

Hiroshi Maeda ◽

Kazuya Narushima ◽

Diane R. Mould ◽

Douglas Greene

Keyword(s):

T Cell ◽

Cell Lymphoma ◽

Pharmacokinetic Modeling ◽

T Cell Lymphoma ◽

Population Pharmacokinetic ◽

Cutaneous T Cell Lymphoma ◽

Population Pharmacokinetic Modeling